We are live on ! Find out more
OPK icon

Opko Health

200 hedge funds and large institutions have $377M invested in Opko Health in 2019 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 56 increasing their positions, 56 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

8% more first-time investments, than exits

New positions opened: 26 | Existing positions closed: 24

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

0% more repeat investments, than reductions

Existing positions increased: 56 | Existing positions reduced: 56

0% less funds holding

Funds holding: 201200 (-1)

0.81% less ownership

Funds ownership: 25.92%25.11% (-0.81%)

10% less capital invested

Capital invested by funds: $418M → $377M (-$41.4M)

45% less call options, than puts

Call options by funds: $5.45M | Put options by funds: $9.84M

Holders
200
Holders Change
-1
Holders Change %
-0.5%
% of All Funds
4.34%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
26
Increased
56
Reduced
56
Closed
24
Calls
$5.45M
Puts
$9.84M
Net Calls
-$4.39M
Net Calls Change
+$13.8M
Name Holding Trade Value Shares
Change
Change in
Stake
DekaBank Deutsche Girozentrale
51
DekaBank Deutsche Girozentrale
Germany
$871K +$333K +152,774 +64%
New York State Common Retirement Fund
52
New York State Common Retirement Fund
New York
$850K +$99.5K +45,600 +15%
USAA
53
United Services Automobile Association
Texas
$849K +$27.9K +12,800 +4%
MIH
54
Meitav Investment House
Israel
$806K -$43.6K -20,000 -6%
SO
55
STRS Ohio
Ohio
$788K +$49.1K +22,500 +7%
Deutsche Bank
56
Deutsche Bank
Germany
$703K -$486K -222,821 -44%
Principal Financial Group
57
Principal Financial Group
Iowa
$675K +$355K +162,865 +143%
Jane Street
58
Jane Street
New York
$633K -$307K -140,562 -35%
T. Rowe Price Associates
59
T. Rowe Price Associates
Maryland
$626K +$2.36K +1,081 +0.4%
Balyasny Asset Management
60
Balyasny Asset Management
Illinois
$608K +$543K +249,098 New
Citadel Advisors
61
Citadel Advisors
Florida
$594K -$4.16M -1,906,897 -89%
Manulife (Manufacturers Life Insurance)
62
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$578K +$38.4K +17,584 +8%
TA
63
Teton Advisors
New York
$561K +$416K +190,700 +485%
ProShare Advisors
64
ProShare Advisors
Maryland
$546K -$56.4K -25,848 -10%
Group One Trading
65
Group One Trading
Illinois
$535K -$4.22M -1,933,348 -90%
AIG
66
American International Group
New York
$527K +$23.7K +10,857 +5%
UBS AM
67
UBS AM
Illinois
$525K -$132K -60,655 -22%
GF
68
Gabelli Funds
New York
$477K -$94.9K -43,500 -18%
RJA
69
Raymond James & Associates
Florida
$459K +$12.2K +5,602 +3%
CCG
70
Ceeto Capital Group
Florida
$449K +$19.6K +9,000 +5%
State Board of Administration of Florida Retirement System
71
State Board of Administration of Florida Retirement System
Florida
$441K
LTFS
72
Ladenburg Thalmann Financial Services
Florida
$420K -$34.4K -15,788 -8%
AQR Capital Management
73
AQR Capital Management
Connecticut
$419K +$375K +171,725 New
GCP
74
GSA Capital Partners
United Kingdom
$359K -$48K -21,985 -13%
MIM
75
MetLife Investment Management
New Jersey
$358K

OPK Hedge Fund Activity: Q2 2019 in Review

200 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Opko Health (OPK) for Q2 2019, worth a combined $377M — down 9.9% from $418M a quarter earlier.

Buyers outnumbered sellers: 26 funds opened new OPK positions and 24 closed out — a net gain of 2 holders — while 56 added to existing stakes and 56 trimmed.

The largest buyer was Nuveen, opening a new position worth an estimated $4.28M. The largest seller was Invesco, cutting an estimated $5.94M.

  • 200 institutional investors held Opko Health (OPK) as of Q2 2019, down from 201 in Q1 2019.
  • Funds reported $377M of Opko Health stock for Q2 2019, down 9.9% quarter-over-quarter.
  • 26 funds opened new Opko Health positions in Q2 2019 and 24 closed out, a net change of +2 holders.
  • The largest Opko Health buyer in Q2 2019 was Nuveen, an estimated $4.28M added.
  • The largest Opko Health seller in Q2 2019 was Invesco, an estimated $5.94M sold.

Based on aggregated 13F filings for Q2 2019.